Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil and Risk of Pulmonary Aspiration
NCT01495377Phase 4Completed
- Sponsor
- Region Örebro län
- Start
- Jan 2012
- Primary completion
- May 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of remifentanil in dysphagia, sponsored by Region Örebro län. Started Jan 2012; status: completed.
02
Drugs
remifentanil
03
Conditions
dysphagia
Beyond the preview
Go deeper on NCT01495377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01495377.